Sunday, September 19, 2021
- Advertisement -spot_img



Telangana mulls free vaccine for all

CM seeks details on demographics, requirement and sourcing of vaccines

Rhetoric with no road map

Modi’s address appeared like yet another event management exercise, a favourite trope of the present leadership

Hong Kong vaccination drive struggles to gain public trust

Hong Kong is still grappling with coronavirus outbreaks and stringent social distancing measures that are especially hard on bars, restaurants and the tourism industry.

Hong Kong suspends Pfizer vaccines over packaging defects

BioNTech and Fosun Pharma have not found any reason to believe the product is unsafe, according to a statement by the Hong Kong government.

Vax-induced antibodies may be less effective against new Covid variants

"We were able to leverage the unique high-throughput capacity that was already in place and apply it to SARS-CoV-2," said researcher Alejandro Balazs from Massachusetts General Hospital in the US.

Pfizer, Moderna vaccines may reduce risk of asymptomatic COVID-19 infection

The Pfizer-BioNTech and Moderna messenger RNA (mRNA) vaccines for COVID-19 are authorised for emergency use in many countries.

Pfizer-BioNTech vaccine can protect against Brazil variant: Study

According to CNN, blood serum samples from people who had received two doses of the Pfizer-BioNtech vaccine "efficiently" neutralised a version of the virus.

COVID-19: New Zealand to only use Pfizer vaccine

So far, New Zealand's medical regulators have approved only the Pfizer vaccine and are reviewing two other shots.

Russia used fake news sites to malign Pfizer, other vaccines

Citing US officials, the report said on Sunday that four online publications linked to Russian intelligence agencies have been spreading misleading information about Covid-19 vaccines.

How do we know the COVID-19 vaccines are safe?

Different types of COVID-19 vaccines have been authorised and it's possible side effects will differ for each.

Pfizer-BioNTech to get EU 200 million more COVID-19 shots

The US and German companies said in a statement that the doses come on top of the 300 million initially ordered.

Japan formally approves its first COVID-19 vaccine

Under the current plan, about 20,000 front-line medical workers at hospitals in Japan will get their first shots beginning around Wednesday.

‘Pfizer vaccine can neutralise coronavirus variants first reported in UK, SA’

The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations.

New AI tool can prevent coronavirus mutations: Study

The AI-assisted method predicted 26 potential vaccines that would work against the coronavirus.

Pfizer withdraws Emergency Use Authorisation application in India

Pfizer will continue to engage with the authority and resubmit its approval request with additional information as it becomes available in the near future.

Pfizer-BioNTech to produce 2 bn doses of Covid vaccine in 2021

"In order to respond to an increased global demand, we plan to manufacture two billion doses of our Covid-19 vaccine in 2021 by expanding the previously expected output of 1.3 billion doses by more than 50 per cent," BioNTech said in a statement

Pfizer vaccine may protect against UK variant of coronavirus: Study

In a yet-to-be peer reviewed research, scientists from the University of Texas Medical Branch, tested the ability of blood serum from 20 individuals immunised with the Pfizer-BioNTech vaccine to neutralise coronavirus engineered to carry the new mutations

Bharat Biotech rejects criticism on ‘Covaxin’ approval

The approval to Covaxin has been questioned by industry experts and some opposition Congress leaders who have expressed concern over the absence of phase 3 trial data

Pfizer delays vaccine deliveries to 8 EU nations: Spain

The Spanish branch of Pfizer informed Madrid on Sunday night of the delay in shipments to the eight nations due to a "problem in the loading and shipment process" at its plant in Belgium, the health ministry said in a statement.

Covid virus will stay with us for next 10 years: BioNTech CEO

In a virtual press conference this week, Sahin spoke about the potential virus deadline when asked when life could return to normal.

Latest news

- Advertisement -spot_img
Telangana Today